127.42
price up icon0.89%   1.12
after-market After Hours: 127.42
loading

Abbott Laboratories Stock (ABT) Latest News

pulisher
Mar 19, 2025

Medtronic, Abbott Block Boston Scientific Heart Valve IP - Law360

Mar 19, 2025
pulisher
Mar 19, 2025

Abbott launches portable concussion blood test in UK - Medical Device Network

Mar 19, 2025
pulisher
Mar 19, 2025

Abbott Laboratories: An Insight Into Its Medtech & Diagnostic Growth Trajectory & Why It May Not Be Enough To Warrant A ‘Buy’ Rating! - Smartkarma

Mar 19, 2025
pulisher
Mar 19, 2025

Brazil Enteral Nutrition Market Is Booming Worldwide 2025-2032 - openPR

Mar 19, 2025
pulisher
Mar 19, 2025

Medical Nutrition Market Key Players Analysis- Abbott - openPR

Mar 19, 2025
pulisher
Mar 18, 2025

RFK Jr.’s Next Targets Are Companies Making Baby Formula - Bloomberg

Mar 18, 2025
pulisher
Mar 18, 2025

US health agencies announce plan to strengthen infant formula supply and quality -March 18, 2025 at 02:23 pm EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Abbott Laboratories (ABT): Among the Best Diabetes Stocks to Buy According to Billionaires - Insider Monkey

Mar 18, 2025
pulisher
Mar 18, 2025

Decoding Abbott Laboratories's Options Activity: What's the Big Picture? - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views? - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Personalized Vitamins Market Top Players- BASF SE, Abbott Laboratories. Amway Corporation, Bayer AG, Caligenix. - openPR

Mar 18, 2025
pulisher
Mar 17, 2025

Abbott's Narrow Economic Moat Rests on a Solid Product Portfolio - Morningstar

Mar 17, 2025
pulisher
Mar 17, 2025

Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock? - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

Blood Typing Analysis Report 2024: Market Set to Surge to $6.50 Billion by 2034, PCR and Microarray Techniques Pave the Way - GlobeNewswire Inc.

Mar 17, 2025
pulisher
Mar 17, 2025

Abbott Stock Could Be On The Verge Of A Breakout — Here’s What Smart Money Sees (NYSE:ABT) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 17, 2025

Reckitt’s Mead Johnson, Abbott to face new trial in US infant-formula case - just-food.com

Mar 17, 2025
pulisher
Mar 17, 2025

Abbott Laboratories Insiders Sell US$3.3m Of Stock, Possibly Signalling Caution - Yahoo Finance

Mar 17, 2025
pulisher
Mar 16, 2025

Abbott Laboratories' (NYSE:ABT) earnings growth rate lags the 15% CAGR delivered to shareholders - Simply Wall St

Mar 16, 2025
pulisher
Mar 16, 2025

Abbott Laboratories Basking In A Sharp Turn In Sentiment (NYSE:ABT) - Seeking Alpha

Mar 16, 2025
pulisher
Mar 15, 2025

Why Abbott Laboratories (ABT) Went Down On Thursday? - MSN

Mar 15, 2025
pulisher
Mar 15, 2025

Why Abbott Laboratories (ABT) Went Down On Friday? - Insider Monkey

Mar 15, 2025
pulisher
Mar 14, 2025

Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case - The Wall Street Journal

Mar 14, 2025
pulisher
Mar 14, 2025

Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial - Investopedia

Mar 14, 2025
pulisher
Mar 14, 2025

In a setback for Abbott Laboratories, judge allows new trial in case over formula for premature infants - Chicago Tribune

Mar 14, 2025
pulisher
Mar 14, 2025

Judge Vacates Baby Formula Trial Win For Abbott, Mead - Law360

Mar 14, 2025
pulisher
Mar 14, 2025

‘A Manifest Injustice': Judge Who Sanctioned Abbott’s Counsel Grants New Infant Formula Trial - Law.com

Mar 14, 2025
pulisher
Mar 14, 2025

Sector Update: Health Care -March 14, 2025 at 03:29 pm EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

BofA keeps $150 target on Abbott Labs stock amid retrial news - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott, Reckitt Fall as Judge Grants New Trial on Infant Formula - Bloomberg

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott, Reckitt face new trial over premature infant formula - Reuters.com

Mar 14, 2025
pulisher
Mar 14, 2025

That baby formula trial Abbott and Reckitt won isn't over just yet - Crain's Chicago Business

Mar 14, 2025
pulisher
Mar 14, 2025

Judge orders retrial in Abbott, Reckitt infant formula case - Seeking Alpha

Mar 14, 2025
pulisher
Mar 14, 2025

Citi maintains Abbott stock Buy rating, $160 target amid legal updates By Investing.com - Investing.com South Africa

Mar 14, 2025
pulisher
Mar 14, 2025

Is Abbott Laboratories (ABT) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Citi maintains Abbott stock Buy rating, $160 target amid legal updates - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott, Reckitt face new trial over premature infant formula -March 14, 2025 at 11:09 am EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

Positive Long-Term Outlook for Abbott Laboratories Despite Short-Term NEC Litigation Risks - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott sends film crew to highlight partnership with Auburn Community Hospital - The Citizen

Mar 14, 2025
pulisher
Mar 14, 2025

Abbott stock falls following retrial order in infant formula case - Investing.com

Mar 14, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 13, 2025

Abbott (ABT) Stock Moves -0.3%: What You Should Know - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - MSN

Mar 13, 2025
pulisher
Mar 12, 2025

Abbott (ABT) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Glucose Biosensor Market Booming with Technological Advancements | Industry Insights Abbott Laboratories, - EIN News

Mar 12, 2025
pulisher
Mar 12, 2025

Here's Why We Think Abbott Laboratories (NYSE:ABT) Might Deserve Your Attention Today - Yahoo Finance

Mar 12, 2025
pulisher
Mar 11, 2025

OTC Consumer Health Market Positioned for Accelerated Growth with Johnson&Johnson, Abbott Laboratories, - EIN News

Mar 11, 2025
pulisher
Mar 11, 2025

EPD Expansion Supports Abbot Stock, Macro Issues Prevail - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Neurological Biomarkers: Global Market Review 2020-2024 and - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Abbott Laboratories (NYSE:ABT) Given New $150.00 Price Target at Bank of America - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment - Benzinga

Mar 10, 2025
pulisher
Mar 10, 2025

BofA Raises Price Target on Abbott Laboratories to $150 From $133 -March 10, 2025 at 10:06 am EDT - Marketscreener.com

Mar 10, 2025
medical_devices BSX
$100.73
price up icon 1.52%
medical_devices SYK
$378.05
price up icon 0.57%
medical_devices MDT
$91.87
price down icon 0.37%
medical_devices EW
$70.90
price up icon 0.80%
$82.40
price up icon 0.32%
Cap:     |  Volume (24h):